TrivarX (ASX:TRI) Price-to-Tangible-Book : (As of Jun. 07, 2024)

View and export this data going back to 2001. Start your Free Trial

What is TrivarX Price-to-Tangible-Book?

As of today (2024-06-07), TrivarX's share price is A$0.029. TrivarX's Tangible Book per Share of Dec. 2023 for the quarter that ended in Dec. 2023 was A$-0.00. Hence, TrivarX's Price to Tangible Book Ratio of today is .

The historical rank and industry rank for TrivarX's Price-to-Tangible-Book or its related term are showing as below:

During the past 13 years, TrivarX's highest Price to Tangible Book Ratio was 37.36. The lowest was 5.39. And the median was 7.90.

ASX:TRI's Price-to-Tangible-Book is not ranked ^*
in the Healthcare Providers & Services industry.
Industry Median: 3.135
* Ranked among companies with meaningful Price-to-Tangible-Book only.

A closely related ratio is called PB Ratio. As of today, TrivarX's share price is A$0.029. TrivarX's Book Value per Sharefor the quarter that ended in Dec. 2023 was A$0.03. Hence, TrivarX's P/B Ratio of today is 1.16.

TrivarX Price-to-Tangible-Book Historical Data

The historical data trend for TrivarX's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

TrivarX Price-to-Tangible-Book Chart

TrivarX Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Price-to-Tangible-Book

Get a 7-Day Free Trial

7.37

TrivarX Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Price-to-Tangible-Book	Get a 7-Day Free Trial															18.33	-	-	-	-

Competitive Comparison of TrivarX's Price-to-Tangible-Book

For the Health Information Services subindustry, TrivarX's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

TrivarX's Price-to-Tangible-Book Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, TrivarX's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where TrivarX's Price-to-Tangible-Book falls into.

TrivarX Price-to-Tangible-Book Calculation

TrivarX's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book	=	Share Price	/	Tangible Book per Share (Q: Dec. 2023 )
	=	0.029	/	-0.002
	=

It can also be calculated from the numbers for the whole company:

Price to Tangible Book	=	Market Cap	/	Tangible Equity
	=	Market Cap	/	(Total Stockholders Equity	-	Preferred Stock	-	Intangible Assets)

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.

TrivarX Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of TrivarX's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.

TrivarX (ASX:TRI) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » TrivarX Ltd (ASX:TRI) » Definitions » Price-to-Tangible-Book

Comparable Companies

Traded in Other Exchanges

MDBIF:USA

Address

647 Beaufort Street, Mount Lawley, WA, AUS, 6050

Website

https://www.medibio.com.au

TrivarX Ltd Formerly Medibio Ltd is a medical technology company. The principal activity of the company is conducting clinical research, product development, and early-stage commercialization of mental health technology using objective biomarkers to assist in the screening, diagnosing monitoring, and management of depression and other mental health conditions. It serves both consumer and healthcare provider markets. In addition, the company offers various psychological services to customers in Australia. The company operates in two geographical markets; Australia and the United States. The company has one operating segment, being the research, development, and commercialization of its Software as a Service product.